INSIGHTS ON CLINICAL TRIAL DESIGN
-
![digital-biomarkers-GettyImages-2246115813]( "How Pharmacometrics Informs Dose Selection And Biomarker Decisions")
How Pharmacometrics Informs Dose Selection And Biomarker DecisionsQuantitative modeling guides early dose and biomarker insights, reducing uncertainty, improving study design, and enabling faster, more confident decisions from first trials to clinical progress.
-
![GettyImages-1279370267 opthalmic study]( "The Hidden Complexity Of Ophthalmic Protocol Requirements")
The Hidden Complexity Of Ophthalmic Protocol RequirementsExplore the critical role of meticulously planning ophthalmic assessments in clinical trials, highlighting their potential risks and complexities.
-
![GettyImages-1330168130-facility-design-blueprint-planning-construction]( "Making Early Decisions In Psychiatric Drug Development")
Making Early Decisions In Psychiatric Drug DevelopmentQuantitative PD measures provide objective evidence of target engagement, support dose selection, strengthen early go/no-go decisions, and help reduce development risk in psychiatric
-
![GettyImages-2200128716-software-ai-machine-learning-percentages-code]( "Streamlining The Clinical Trial Workflow From Protocol Design To Regulatory Submission")
Streamlining The Clinical Trial Workflow From Protocol Design To Regulatory SubmissionLearn how to create a direct line from clinical planning and protocol design to clinical trial disclosure to optimize efficiency across the entire trial lifecycle.
-
Biotech Landscape Continues To Shift9/18/2025
Global shifts are adding new layers of challenge and opportunity for the biotech sector, as companies navigate a period of unprecedented complexity.
-
Adaptive Clinical Trials: Innovation With Hidden Challenges5/8/2026
Adaptive trial designs offer faster results and better patient care, but only if site infrastructure can keep up with the operational complexity of these highly flexible research models.
-
Anthropic's Stainless Acquisition: What It Means For Clinical Trials6/5/2026
As AI models become interchangeable, value is shifting to the orchestration layer that connects tools, workflows, and governance—making flexibility, interoperability, and auditability critical.
-
Decentralized Trials Still Need Connected Support7/23/2026
Decentralized and hybrid trials reduce travel burdens but add coordination challenges. Strong support improves communication, engagement, and smooth trial execution from enrollment to completion.
-
Hybrid Ophthalmic Trials: Splitting Visits Across Home, Hub, And Site12/23/2025
Hybrid ophthalmic trials combine in-person and remote visits, boosting patient convenience, reducing site burden, and accelerating timelines while maintaining data quality and compliance.
CLINICAL TRIAL DESIGN SOLUTIONS
-
![GettyImages-1441662840-lab-team-communication-collaboration]( "Integrated Programs To Bridge Molecules From Discovery Into Clinical Development")
A new collaboration helps to remove obstacles from the critical path, reduce development risks, eliminate the white space in pre-clinical drug development, and shorten the pathway to clinical development.
-
![GettyImages-1819626829 patient recruitment]( "Precision Recruitment Is the Name of the Game")
Leverage an exhaustive view of patients, diseases, and providers to precisely identify protocol-specific populations within a sponsor’s site network.
-
![GettyImages-1364220293 driving]( "Premier Service Provider For Driving Simulator Clinical Trials")
With over 13,000 drives completed and 10 driving simulators on-site, Altasciences is the ideal full-service provider for your driving simulator clinical trials.
-
![GettyImages- 1254443202 medical writing]( "Medical Writing Services To Support Every Submission Milestone")
Ensure accurate, compliant, and impactful documentation with Altasciences' experienced medical writers and regulatory experts.
-
![clinical-trials-cros-GettyImages-1346675527]( "Deliver Supply Without Friction. Maintain Control At Every Step")
Learn how clinical supply organizations can reduce manual effort, strengthen compliance, improve global coordination, and maintain control across evolving clinical trial supply chains.
